Home
News
默认头像

Skye Bioscience Appoints Puneet Arora As New Chief Medical Officer

2024-12-18iFOREXiFOREX
Biopharmaceutical company Skye Bioscience, Inc. (SKYE) announced Tuesday the appointment of Puneet Arora as Chief Medical Officer (CMO)."/> <meta property="og:site_name" content="Myfxbook.com
Skye Bioscience Appoints Puneet Arora As New Chief Medical Officer

(RTTNews) - Biopharmaceutical company Skye Bioscience, Inc. (SKYE) announced Tuesday the appointment of Puneet Arora as Chief Medical Officer (CMO).

Arora is a board-certified physician in endocrinology, diabetes and metabolism. His career includes serving as a physician-scientist, drug developer and executive leader with more than 15 years of experience in designing and executing all phases of clinical trials across multiple therapeutic areas, regulatory submissions, and medical affairs in addition to fundraising with small biotech and large pharma.

Arora was CMO at Lassen Therapeutics. He joined Lassen at the preclinical stage. He previously served as Head of Clinical Development at Principia Biopharma, a Sanofi company. He also served as Senior Medical Director, Early Clinical Development and Clinical Team Leader, Inflammation/Cardiovascular-Metabolism, at Genentech Research and Early Development.

Disclaimers

The article is sourced from myfx with the original source credited. The views expressed herein are not affiliated with FXOR; readers are encouraged to approach the content rationally. Copyright belongs to the original author. If unintentional infringement upon media or personal intellectual property rights has occurred, please contact us, and we will promptly remove the content. FXOR merely provides information storage services. The article is compiled and released by FXOR; reprints must indicate the original source.